CRMD - CorMedix Inc.

QQQ $ 442.96 $ -0.45 (-0.1 %)

DIA $ 394.52 $ -0.66 (-0.17 %)

SPY $ 520.61 $ -1.98 (-0.38 %)

TLT $ 90.36 $ 0.04 (0.04 %)

GLD $ 216.28 $ -2.43 (-1.11 %)

Previous Close

$ 5.17

Open

$ 5.22

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 5.12 - $ 5.31

52 Week Range

$ 2.57 - $ 7.00

Volume

991,715

Average Volume

Market Cap

284.14M

Beta (5Y Monthly)

$ 1.79

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-12-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-30-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-29-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-30-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	03-16-2020	12-31-2019	10-K
19	11-14-2019	09-30-2019	10-Q
20	08-14-2019	06-30-2019	10-Q
21	05-13-2019	03-31-2019	10-Q
22	03-14-2019	12-31-2018	10-K
23	11-14-2018	09-30-2018	10-Q
24	08-14-2018	06-30-2018	10-Q
25	05-15-2018	03-31-2018	10-Q
26	03-19-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-12-2015	09-30-2015	10-Q
36	08-06-2015	06-30-2015	10-Q
37	05-07-2015	03-31-2015	10-Q
38	03-12-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Cormedix, Mainta...
05/13/2024 09:32:37

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

Cormedix Q1 2024 GAAP EPS $(0.25) Beats $(...
05/09/2024 11:36:03

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.28) by 1...

CorMedix Inc. Announces CMS Grants Transit...
04/19/2024 12:31:44

CorMedix Announces U.S. Inpatient Commerci...
04/15/2024 12:40:19

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/12/2024 20:31:04

Two Of CorMedix Abstracts Accepted For Pre...
04/11/2024 12:37:54

JMP Securities Reiterates Market Outperfor...
04/09/2024 12:39:35

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

Needham Reiterates Buy on Cormedix, Mainta...
04/09/2024 10:08:10

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

CorMedix Inc. Announces 5-Year Contract Wi...
04/08/2024 12:41:21

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

RBC Capital Maintains Outperform on Cormed...
03/13/2024 14:57:29

RBC Capital analyst Gregory Renza maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $10 to...

Needham Maintains Buy on Cormedix, Maintai...
03/12/2024 20:35:12

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

Cormedix Q4 GAAP EPS $(0.26) Misses $(0.20...
03/12/2024 11:33:04

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.20) by...

Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Cormedix Earnings Preview
03/11/2024 18:01:18

Truist Securities Maintains Buy on Cormedi...
01/31/2024 18:43:54

Truist Securities analyst Joon Lee maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $18 to $14.

CorMedix Inc. Announces Commercial And Ope...
01/08/2024 13:54:31

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. Announces Partnership With T...
12/04/2023 13:36:10

– CorMedix to advocate for patient safety and infection prevention as part of Leapfrog's Partners Advisory CommitteeBERKELE...

Why CorMedix Stock Popped Wednesday
11/15/2023 21:12:35

CorMedix Inc. (NASDAQ: CRMD) shares traded higher Wednesday after the company reported better-than-expected third-quarter earni...

why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Shapeways Holdings Shares Are Trading ...
11/15/2023 19:04:31

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

Needham Maintains Buy on Cormedix, Lowers ...
11/15/2023 18:52:08

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $12 to $10.